Kelsey Stephen Michael 4
4 · Revolution Medicines, Inc. · Filed Oct 15, 2025
Insider Transaction Report
Form 4
Kelsey Stephen Michael
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2025-10-13$4.73/sh+25,000$118,250→ 309,047 total - Sale
Common Stock
2025-10-13$48.54/sh−25,000$1,213,540→ 284,047 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-10-13−25,000→ 5,055 totalExercise: $4.73From: 2023-08-09Exp: 2029-08-08→ Common Stock (25,000 underlying)
Footnotes (3)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025.
- [F2]Includes 84,000 restricted stock units.
- [F3]The transaction was executed in multiple trades in prices ranging from $48.03 to $48.99, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.